Cargando…
Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
Tumor as source of tumor associated antigens (TAA) and sentinel lymph node (SLN) configure the first interaction between the malignant disease and the patient’s immune system. As consequence of this interaction, a local immune response is elicited inside the SLN. Tumor’s cytokines reach the SLN cond...
Autores principales: | Lasalvia-Prisco, Eduardo, Garcia-Giralt, Emilio, Cucchi, Silvia, Vázquez, Jesús, Robinson, Leonard, Dalton, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721301/ https://www.ncbi.nlm.nih.gov/pubmed/19707327 |
Ejemplares similares
-
Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies
por: Shukla, Girja S., et al.
Publicado: (2017) -
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2008) -
In adjuvant-induced arthritis the disease-triggering adjuvant squalene accumulates in draining lymph nodes but not affected joints
por: Holm, BC, et al.
Publicado: (2001) -
L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells
por: Heo, Yoonki, et al.
Publicado: (2023) -
Coimmunomodulation of tumor and tumor-draining lymph nodes during in situ vaccination promotes antitumor immunity
por: Jeong, Moonkyoung, et al.
Publicado: (2022)